An investor asked a question on the investor interaction platform: according to the 2021 semi annual report, the overall operating revenue of Sinopharm business unit is 1301740600 yuan. Is Sinopharm business unit a traditional Chinese medicine?
Yifan Pharmaceutical Co.Ltd(002019) (002019. SZ) said on the investor interaction platform on December 30 that the operating revenue of Sinopharm business division includes the revenue from the company’s own pharmaceutical products, cooperative sales products and market promotion services, of which the self owned pharmaceutical products are mainly traditional Chinese medicine products.
(Daily Economic News)
